Rachel Davies, a 40-year-old cancer patient in Wales, is advocating for access to the life-extending drug Enhertu, which is available in Scotland and 19 other European countries. Diagnosed with secondary breast cancer in 2021, Rachel has been denied the drug due to funding constraints stipulated by NICE, the health assessment body in the UK. While the drug can potentially extend her life by six months, the Welsh government relies on NICE’s recommendations, leading to growing calls from patients and charities like Breast Cancer Now for improved access to critical treatments.